Literature DB >> 24590924

Ectopic expression of RBP4 impairs the insulin pathway and inguinal fat deposition in mice.

Jia Cheng1, Yuefeng Li, Guofang Wu, Jiameng Zheng, Hongzhao Lu, Xin'e Shi, Gongshe Yang.   

Abstract

A large body of evidence has linked retinol-binding protein 4 (RBP4) to systemic insulin resistance, but little is known about its function in fat deposition. This study aimed to confirm the involvement of RBP4 in inguinal fat deposition and insulin by intraperitoneal injection of adenovirus-mediated RBP4 to mice. Intraperitoneal injection of adenoviral vectors was validated as an efficient gene manipulation tool for over-expressing recombinant proteins in vivo. Ectopic expression of RBP4 decelerated inguinal fat deposition by decreasing the size of adipocytes. Moreover, the introduction of exogenous RBP4 blunted the response of inguinal adipocytes to insulin signals. These findings suggest that RBP4 impaired in vivo adipogenesis, partly through the repression of the insulin pathway.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24590924     DOI: 10.1007/s13105-014-0326-3

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  25 in total

Review 1.  RBP4: a controversial adipokine.

Authors:  Primoz Kotnik; Pamela Fischer-Posovszky; Martin Wabitsch
Journal:  Eur J Endocrinol       Date:  2011-08-10       Impact factor: 6.664

2.  Serum retinol binding protein 4 level is related with renal functions in Type 2 diabetes.

Authors:  E Akbay; N Muslu; E Nayir; O Ozhan; A Kiykim
Journal:  J Endocrinol Invest       Date:  2010-04-30       Impact factor: 4.256

3.  Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.

Authors:  Timothy E Graham; Qin Yang; Matthias Blüher; Ann Hammarstedt; Theodore P Ciaraldi; Robert R Henry; Christopher J Wason; Andreas Oberbach; Per-Anders Jansson; Ulf Smith; Barbara B Kahn
Journal:  N Engl J Med       Date:  2006-06-15       Impact factor: 91.245

4.  Retinol binding protein 4 affects the adipogenesis of porcine preadipocytes through insulin signaling pathways.

Authors:  Jia Cheng; Zi-Yi Song; Lei Pu; Hao Yang; Jia-Meng Zheng; Zhen-Yu Zhang; Xin-E Shi; Gong-She Yang
Journal:  Biochem Cell Biol       Date:  2013-03-12       Impact factor: 3.626

5.  Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients.

Authors:  Fatma Ulgen; Christian Herder; Markus C Kühn; Holger S Willenberg; Matthias Schott; Werner A Scherbaum; Sven Schinner
Journal:  Arch Physiol Biochem       Date:  2010-05       Impact factor: 4.076

6.  RBP-to-retinol ratio, but not total RBP, is elevated in patients with type 2 diabetes.

Authors:  C Erikstrup; O H Mortensen; A R Nielsen; C P Fischer; P Plomgaard; A M Petersen; R Krogh-Madsen; B Lindegaard; J G Erhardt; H Ullum; C S Benn; B K Pedersen
Journal:  Diabetes Obes Metab       Date:  2009-03       Impact factor: 6.577

7.  Hyperinsulinemia drives diet-induced obesity independently of brain insulin production.

Authors:  Arya E Mehran; Nicole M Templeman; G Stefano Brigidi; Gareth E Lim; Kwan-Yi Chu; Xiaoke Hu; Jose Diego Botezelli; Ali Asadi; Bradford G Hoffman; Timothy J Kieffer; Shernaz X Bamji; Susanne M Clee; James D Johnson
Journal:  Cell Metab       Date:  2012-12-05       Impact factor: 27.287

8.  Abdominal visceral fat reduction is associated with favorable changes of serum retinol binding protein-4 in nondiabetic subjects.

Authors:  Ji-Won Lee; Hye-Ree Lee; Jae-Yong Shim; Jee-Aee Im; Duk-Chul Lee
Journal:  Endocr J       Date:  2008-05-21       Impact factor: 2.349

9.  Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes.

Authors:  Weiping Jia; Haiya Wu; Yuqian Bao; Chen Wang; Junxi Lu; Jiehua Zhu; Kunsan Xiang
Journal:  J Clin Endocrinol Metab       Date:  2007-06-05       Impact factor: 5.958

10.  Adipocyte turnover: relevance to human adipose tissue morphology.

Authors:  Erik Arner; Pål O Westermark; Kirsty L Spalding; Tom Britton; Mikael Rydén; Jonas Frisén; Samuel Bernard; Peter Arner
Journal:  Diabetes       Date:  2009-10-21       Impact factor: 9.461

View more
  6 in total

Review 1.  Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication.

Authors:  Jan-Bernd Funcke; Philipp E Scherer
Journal:  J Lipid Res       Date:  2019-06-17       Impact factor: 5.922

2.  Sirt1 AS lncRNA interacts with its mRNA to inhibit muscle formation by attenuating function of miR-34a.

Authors:  Guo-qiang Wang; Yu Wang; Yan Xiong; Xiao-Chang Chen; Mei-ling Ma; Rui Cai; Yun Gao; Yun-mei Sun; Gong-She Yang; Wei-Jun Pang
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

3.  ALDH1A1 Inhibits Chicken Preadipocytes' Proliferation and Differentiation via the PPARγ Pathway In Vitro and In Vivo.

Authors:  Jing Zhang; Bolin Cai; Manting Ma; Wei Luo; Zipeng Zhang; Xiquan Zhang; Qinghua Nie
Journal:  Int J Mol Sci       Date:  2020-04-29       Impact factor: 5.923

4.  Augmentation of RBP4/STRA6 signaling leads to insulin resistance and inflammation and the plausible therapeutic role of vildagliptin and metformin.

Authors:  Kuppan Gokulakrishnan; Gautam Kumar Pandey; Chandrakumar Sathishkumar; Saravanakumar Sundararajan; Prabhu Durairaj; Nagaraj Manickam; Viswanathan Mohan; Muthuswamy Balasubramanyam
Journal:  Mol Biol Rep       Date:  2021-05-26       Impact factor: 2.316

5.  Changes of serum retinol-binding protein 4 associated with improved insulin resistance after laparoscopic sleeve gastrectomy in Chinese obese patients.

Authors:  Xingchun Wang; Yueye Huang; Jingyang Gao; Hang Sun; Muthukumaran Jayachandran; Shen Qu
Journal:  Diabetol Metab Syndr       Date:  2020-01-14       Impact factor: 3.320

6.  RBP4 Is Associated With Insulin Resistance in Hyperuricemia-Induced Rats and Patients With Hyperuricemia.

Authors:  Chan Liu; Xiao-Rong Zhou; Mu-Yao Ye; Xiang-Qing Xu; Yu-Wei Zhang; Hong Liu; Xian-Zhe Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-10       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.